Although heart valve replacement is a safe and commonly

Size: px
Start display at page:

Download "Although heart valve replacement is a safe and commonly"

Transcription

1 Mitral Valve Relacement: Randomized Trial of St. Jude and Medtronic Hall Prostheses Andrew C. Fiore, MD, Hendrick B. Barner, MD, Marc T. Swartz, BA, Lawrence R. McBride, MD, Arthur J. Labovitz, MD, Kathy J. Vaca, RN, Jan St. Vrain, RDCS, Gary L. Grunkemeier, PhD, and George C. Kaiser, MD Division of Cardiothoracic Surgery and Cardiology, Saint Louis University Health Sciences Center, St. Louis, Missouri Background. This study was designed to better define the merits of the bileaflet and tilting-disc valves. Methods. We rosectively randomized 156 atients (mean age, 59 years) to receive either the St. Jude (n 80) or the Medtronic Hall (n 76) mitral valve rosthesis between Setember 1986 and December The two grous were not significantly different with resect to reoerative New York Heart Association class, left ventricular ejection fraction, incidence of mitral stenosis or insufficiency, extent of coronary artery disease, comleteness of revascularization, or cross-clam or byass time. Results. The oerative mortality (11.2% versus 13.1%, St. Jude versus Medtronic Hall, resectively) and late mortality (27% versus 22%, St. Jude versus Medtronic Hall, resectively) were not significantly different. Follow-u was comlete in all hosital survivors with a mean of 60.7 months (range, 1 to 133 months). The analysis of 10-year actuarial survival and freedom from valve-related events demonstrated no significant differences between the cohorts. Freedom from reoeration was higher in the St. Jude grou ( < 0.01). Comarisons of atient functional status and echocardiograhic hemodynamic arameters obtained at the time of follow-u demonstrated no significant differences between the two rostheses. Conclusions. This study suggests that there is no difference between the St. Jude and Medtronic Hall rostheses with resect to late clinical erformance or hemodynamic results and therefore does not suort the referential selection of either rosthesis. (Ann Thorac Surg 1998;66:707 13) 1998 by The Society of Thoracic Surgeons Although heart valve relacement is a safe and commonly erformed rocedure, all available rostheses are associated with valve-related comlications that influence their clinical use. Two commonly used rosthetic valves in the United States are the bileaflet St. Jude and the tilting-disc Medtronic Hall. Both rostheses ossess secific mechanical features that aear advantageous. The wide oening angle (70 degrees), uward gliding disc, and monostrut construction are attractive roerties of the Medtronic Hall valve, whereas the central flow design of the low-rofile bileaflet St. Jude rosthesis is urorted to be hemodynamically advantageous. To determine whether one rosthesis has clinical or hemodynamic sueriority, we designed a rosective, randomized trial to comare these two valves in atients requiring mitral valve relacement. Material and Methods From Setember 1986 until December 1997, 156 atients undergoing elective valve relacement for mitral valve dysfunction were rosectively randomized to receive Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 26 28, Address rerint requests to Dr Fiore, Deartment of Surgery, Saint Louis University Health Sciences Center, 3635 Vista at Grand Blvd, St. Louis, MO either the Medtronic Hall (MH, 76 atients) or the St. Jude (SJ, 80 atients) mitral rosthesis. Patients requiring emergency oerations and those requiring simultaneous aortic and mitral valve relacement were excluded from this study. Randomization was accomlished by a blind drawing from randomly distributed enveloes. The clinical data recorded included age, sex, admitting diagnosis, cardiac risk factors, rocedure erformed, and ostoerative comlications. A New York Heart Association functional classification was determined for each atient. Angina was graded using the Canadian Cardiovascular Society Classification. Cardiac catheterization data noted include left ventricular end-diastolic ressure, ulmonary artery ressure, cardiac index, left ventricular score (regional wall motion scoring as defined by Coronary Artery Surgery Study) [1], number of major coronary vessels diseased (defined as at least 70% luminal obstruction in any angiograhic lane), resence of left main coronary artery stenosis (defined as 50% luminal obstruction), mitral valve area (calculated using the Gorlin formula), and the resence and severity (grade 0 to 4) of angiograhically determined mitral insufficiency. M-mode, two-dimensional, and Doler echocardiograhy were erformed reoeratively and 1 to 7 years ostoeratively (mean, 2.4 years). Ventricular endsystolic and end-diastolic dimensions were measured, 1998 by The Society of Thoracic Surgeons /98/$19.00 Published by Elsevier Science Inc PII S (98)

2 708 FIORE ET AL Ann Thorac Surg PROSTHETIC MITRAL VALVE 1998;66: and ejection fraction and rosthetic valve gradient were calculated. In atients with atrial fibrillation, the mean of ten consecutive cardiac cycles was calculated. The ejection fraction was calculated by Simson s rule as reviously described [2]. Mitral valve areas were calculated by the ressure half-time method with either continuous or ulsed wave recordings [3, 4]. The resence and degree of rosthetic valve regurgitation was qualitatively assessed by ulsed wave, continuous wave, and color Doler echocardiograhy from multile windows. Exercise studies were erformed on a treadmill using the Bruce or modified Bruce rotocol [5]. The heart rate increased from a mean of 74 to a mean of 123 beats er minute (increase of 46%). The metabolic equivalents increased from 2 to 13 with a mean eak value of Cardioulmonary byass was established using ascending aortic and bicaval cannulation with systemic hyothermia and hemodilution. Myocardial rotection included the use of cold hyerkalemic blood cardiolegia (6 C). The infusate consisted of a 4:1 dilution of blood with 0.9% normal saline solution that contained 20 meq/l sodium bicarbonate and 0.1 mg/ml lidocaine hydrochloride (Xylocaine). The initial infusion contained 14 meq/l of otassium. In atients in whom the aortic valve was cometent, an initial dose (15 ml/kg) was given through the aortic root and subsequent doses (7.5 ml/kg) were infused through the coronary sinus. In atients with aortic insufficiency, all doses of cardiolegic solution were given through the coronary sinus. Toical myocardial cooling with Ringer s lactate slush and a cardiac insulation ad for hrenic nerve rotection were used in all atients. Proximal vein graft anastomoses were erformed using a artially occlusive aortic clam while distal anastomoses were constructed with the aorta cross-clamed. Myocardial revascularization was erformed before mitral valve relacement to avoid raising the heart after the mitral rosthesis had been inserted, thus decreasing the risk of myocardial ruture. The oerative rocedure was erformed by the same grou of surgeons (A.C.F., H.B.B., L.R.M., G.C.K.) using similar techniques. The mitral rosthesis was inserted with interruted horizontal mattress sutures of 2-0 Ethibond (Ethicon, Somerville, NJ) laced through the left atrial side so as to evert the mitral annulus. When feasible, the osterior mitral leaflet was left intact. The St. Jude rosthesis was oriented either in the antianatomic axis erendicular to the mitral commissures or in the anatomic lane arallel to the mitral commissures. The Medtronic Hall valve was generally oriented with the larger orifice oening osteriorly. This rosthesis could be rotated according to the surgeon s reference to revent entrament of the disc by the retained osterior mitral leaflet. Recorded oerative variables included cardioulmonary byass and cross-clam times. Prohylactic anticoagulation with sodium warfarin was carried out in all atients. Anticoagulation was instituted within 48 hours after the oeration unless clinical contraindications existed. The control of theray was made by interval analysis of the international normalized ratio, which was ket between 2.5 and 3.5. Antibiotic rohylaxis consisted of cefazolin sodium (Ancef; Smith Kline & French Laboratories, Philadelhia, PA) administered reoeratively and for 48 hours ostoeratively. Follow-u data were collected by a registered nurse using written questionnaires and telehone interviews with the atient, the atient s hysician, or both. All atients enrolled were contacted yearly for the duration of their articiation in this rosective randomized trial. Patients surviving the oerative eriod were followed u for a minimum of 1 month and a maximum of 133 months (mean, 60.7 months). The mean follow-u was 4.9 years for SJ and 5.1 years for MH (not significant [NS]). The cumulative follow-u was 394 atient-years for the SJ and 395 atient-years for the MH grou. No atient was lost to follow-u. The definitions of events, their classification, and the analysis of the data follow the recently suggested guidelines for reorting morbidity and mortality after cardiac valve rosthesis insertion [6]. Oerative mortality is defined as death in the oerating room, in the hosital, or within 30 days of the oerative rocedure regardless of the atient s geograhic location. Late mortality is defined as death beyond 30 days of the oerative rocedure regardless of the atient s geograhic location. Oerative deaths were all classified as valve-related. Data were analyzed using the Statview for Windows 4.53 statistical software ackage (Abacus Concets, Inc, Berkeley, CA). Univariate analysis of discrete variables was erformed using the 2 analysis or Fisher s exact test where aroriate. Unaired Student s t tests were used for continuous variables. Results are exressed as means the standard deviation excet as noted. The actuarial curves were constructed using the methods described by Kalan and Meier and are reorted with 95% confidence limits. Actuarial curves were comared using a log-rank analysis as described by Mantel-Cox [7]. Hosital deaths were included in the actuarial survival analysis. A value of less than 0.05 was considered significant. Results Clinical Characteristics The cohorts were similar with resect to age, sex, hemodynamic and oerative arameters, and the degree of mitral stenosis or mitral insufficiency (Table 1). The majority of atients had mild left ventricular dysfunction with moderate ulmonary hyertension. Fifteen ercent of atients in both grous had rior valve relacement, and 23% had concomitant myocardial revascularization. Thirty-three ercent of the atients in both cohorts had at least one rior cardiac surgical rocedure. Before oeration, most atients were in New York Heart Association functional class III or IV. After oeration, however, the mean New York Heart Association functional class imroved significantly in both cohorts (SJ, ; MH, ; NS). Oerative Mortality A total of 19 atients (12.1%) died in the hosital or within 30 days of the oerative rocedure. The overall

3 Ann Thorac Surg FIORE ET AL 1998;66: PROSTHETIC MITRAL VALVE 709 oerative mortality was 11.2% for the SJ grou and 13.1% for the MH grou (NS), whereas that for mitral valve relacement with myocardial revascularization was 12.5% and 31%, resectively (NS). The oerative mortality of those atients undergoing redo valve relacement was nearly twofold higher in the SJ cohort (SJ, 15.4%; MH, 8%; NS). The most common cause of oerative death was low cardiac outut syndrome. Eleven atients died as a result of low cardiac outut associated with biventricular failure. In two instances (SJ, 1; MH, 1) oerative death was caused by atrioventricular sulcus ruture. The cause of death in 3 additional atients receiving the Medtronic Hall valve included fatal dysrhythmia, massive cerebral hemorrhage on ostoerative day 1, and an aortic dissection at the aortic cannulation site in a atient with Ehlers-Danlos syndrome. Three additional atients (SJ, 2; MH, 1) died of multiorgan system failure. One atient with a history of chronic heatitis died 13 days ostoeratively of liver and renal failure. A second atient remained comatose ostoeratively. Renal and resiratory failure develoed and the atient died on the fourth ostoerative day. The remaining atient had undergone urgent third-time mitral valve relacement. He died of multiorgan system failure after several hyotensive eisodes on ostoerative day 5. The atients who died in the hosital had a mean New York Heart Association functional class of , and 47% of hosital deaths were in atients with mitral Table 1. Preoerative and Oerative Clinical Profile a Variable SJ MH Age (y) Male sex (%) NYHA class LVEDP (mm Hg) LVEF Pulmonary artery systolic ressure (mm Hg) Cardiac index (L min 1 m 2 ) Mitral area (cm 2 ) Mitral insufficiency Coronary artery disease (%) Prior valve relacement (%) Duration of CPB (min) Cross-clam time (min) Simultaneous CABG (%) Prosthesis size (mm) a s exressed as ercent or mean the standard deviation. CABG coronary artery byass grafting; CPB cardioulmonary byass; LVEDP left ventricular end-diastolic ressure; LVEF left ventricular ejection fraction; MH Medtronic Hall; NYHA New York Heart Association; SJ St. Jude. Fig 1. Actuarial survival rates after mitral valve relacement with the St. Jude (SJ) and Medtronic Hall (MH) valves. Oerative and late deaths are included. (NS not significant.) regurgitation as the rimary athologic rocess. Univariate analysis demonstrated that the resence of left ventricular ejection fraction less than 0.40 correlated with oerative mortality ( 0.05). Coronary artery disease, a history of hyertension, and cardioulmonary byass time were marginally significant redictors of oerative mortality ( 0.05 to 0.1). Sex, ulmonary artery systolic ressure, and global ischemic time were not correlated with hosital death. Multivariate analysis failed to demonstrate any redictors of oerative mortality. Late Mortality There were a total of 39 late deaths recorded after mitral valve relacement: 22 in atients receiving the St. Jude valve and 17 in atients receiving the Medtronic Hall valve (SJ, 27%; MH, 22%; NS). Valve-related comlications were the cause of late death in 12 atients (SJ 5, 12.8%; MH 7, 17.9%; NS). The most common cause of valve-related death was cerebrovascular accident, which accounted for five valve-related late deaths (SJ, 4; MH, 1) at 31, 47, 54, 72, and 91 months ostoeratively. Sudden death occurred at home in 3 atients (all in the MH grou) at 23, 24, and 34 months ostoeratively. Two of these atients had known coronary artery disease, an ejection fraction less than 40%, and ulmonary hyertension. Three atients (SJ, 2; MH, 1) died of congestive heart failure at 3.3, 53, and 55 months ostoeratively secondary to aravalvular leak. The remaining valve-related late death (MH) was secondary to generalized sesis from bacterial endocarditis 2.3 months after valve imlantation. Patient Survival The actuarial survival curve for the oulation is shown in Figure 1. At 5 and 10 years the survival rates were nearly identical for atients receiving either the Medtronic Hall or the St. Jude mitral valve. Patients who underwent mitral valve relacement were found to have a significantly higher 10-year actuarial survival in the absence of coexisting coronary artery disease (63% versus 30%; 0.05).

4 710 FIORE ET AL Ann Thorac Surg PROSTHETIC MITRAL VALVE 1998;66: Table 2. Actuarial 10-Year Freedom From Events a Event SJ MH Survival Thromboembolism Hemorrhage Endocarditis Paravalvular leak Reoeration All valve-related events a s exressed as ercent standard error of mean. MH Medtronic Hall; NS not significant; SJ St. Jude. Fig 3. Actuarial freedom from thromboembolism after mitral valve relacement with the St. Jude (SJ) and Medtronic Hall (MH) valves. (NS not significant.) Valve-Related Comlications During the eriod of oerative hositalization, there were no valve-related events in any atient other than death. The actuarial freedom from these morbid events is shown in Table 2 and Figure 2. STRUCTURAL DETERIORATION. Structural deterioration did not occur in any atient in this study. THROMBOEMBOLISM. There were a total of 26 eisodes of thromboembolism occurring in 26 atients and 5 were fatal. Valve thrombosis occurred in 4 atients, 2 in each grou. One atient died of metastatic disease with clot on the St. Jude valve at 1.8 months ostoeratively. Two atients (SJ, 1; MH, 1) underwent successful reoeration with insertion of a orcine biorosthesis at 18 and 43 months ostoeratively. The remaining atient with valve thrombosis had successful thrombolytic theray 72 months after imlant. These latter 3 atients are longterm survivors. Nine atients who exerienced transient ischemic attack (SJ, 4; MH, 5) had resumed embolic events at a mean of 42 months ostoeratively in both cohorts. The earliest transient ischemic attack occurred at 0.5 months ostoeratively. Seventeen atients exerienced a cerebrovascular accident (SJ, 8; MH, 9) of which 4 (SJ, 3; MH, 1) were fatal. The actuarial freedom from thromboembolism was equal in both cohorts (Fig 3). HEMORRHAGE. There were 14 instances of hemorrhage related to anticoagulant treatment (SJ, 9; MH, 5). Bleeding occurred intracerebrally in 2 atients and was fatal in 1 at 72 weeks ostoeratively. Surgical bleeding develoed in 3 atients (SJ, 2; MH, 1) after elective rocedures whereas 7 atients (SJ, 4; MH, 3) had nonfatal gastrointestinal hemorrhage that did not require oeration. The 2 remaining atients (MH, 2) exerienced nonfatal hemorrhage. One atient had a retroeritoneal hematoma after a motor vehicle accident and the final atient had disseminated intravascular coagulation associated with a ulmonary embolism. Both atients were treated nonoeratively and are long-term survivors. The actuarial freedom from hemorrhage at 10 years was slightly higher in the Medtronic Hall grou, but the difference was not significant (Fig 4). ENDOCARDITIS. Bacterial endocarditis with a aravalvular leak develoed in 4 atients, all in the Medtronic Hall grou. One atient underwent reoeration at 1.5 months ostoeratively with insertion of a orcine valve and survived 34 months, dying of comlications secondary to chronic dialysis. Two atients who did not undergo reoeration died at 2 and 34 months ostoeratively of multiorgan system failure. The remaining atient had stretococcal endocarditis, which was treated medically, and he continues to be a long-term survivor. The 10-year actuarial freedom from endocarditis was not significantly different between cohorts. PARAVALVULAR LEAK. Paravalvular leak develoed in eleven atients (SJ, 5; MH, 6). Three atients underwent reo- Fig 2. Actuarial freedom from all valve-related events after mitral valve relacement with the St. Jude (SJ) and Medtronic Hall (MH) valves. (NS not significant.) Fig 4. Actuarial freedom from hemorrhage after mitral valve relacement with the St. Jude (SJ) and Medtronic Hall (MH) valves. (NS not significant.)

5 Ann Thorac Surg FIORE ET AL 1998;66: PROSTHETIC MITRAL VALVE 711 Table 4. Postoerative Exercise Transvalvular Echocardiograhic Mean Gradient Valve Size (mm) Gradient (mm Hg) SJ (n 22) MH (n 26) Fig 5. Actuarial freedom from reoeration after mitral valve relacement with the St. Jude (SJ) and Medtronic Hall (MH) valve. eration with one oerative death and 2 long-term survivors. Of the remaining 8 atients, 2 died at 3 and 53 months of congestive heart failure and sudden unexlained death, resectively. The remaining 6 atients are long-term survivors. The 10-year actuarial freedom from aravalvular leak was similar in both cohorts. REOPERATIONS. Seven atients, all in the Medtronic Hall grou, underwent reoeration. The indications for reoeration were aravalvular leak (3), endocarditis (2), valve thrombosis (1), and endocarditis with eriheral emboli in the remaining atient. The oerative mortality for reoeration was 28%. The 10-year actuarial freedom from reoeration was significantly higher in the SJ cohort (Fig 5). POSTOPERATIVE ECHOCARDIOGRAPHY. The ostoerative resting and exercise echocardiograhic analysis are summarized on Tables 3 and 4. The mean transvalvular gradient at rest and with exercise was not significantly different between grous at any valve size. Comment The bileaflet St. Jude and the ivoting-disc Medtronic Hall valve have retained widesread oularity for more than 20 years. These devices have undergone virtually no alteration in design since their develoment in 1977 and 1978 and have remained unmodified throughout this study, which commenced in Although a number of investigators have reorted their clinical and hemodynamic results with these valves, this reort reresents the only rosective randomized trial comaring these rostheses in the mitral osition Table 3. Postoerative Resting Transvalvular Echocardiograhic Mean Gradient Valve Size (mm) Gradient (mm Hg) SJ (n 42) MH (n 41) MH Medtronic Hall; n number of atients; NS not significant; SJ St. Jude MH Medtronic Hall; n number of atients; NS not significant; SJ St. Jude. throughout a 10-year eriod of observation at a single institution [8, 9]. This is imortant because referral atterns may vary from one institution to another as may oerative techniques and ostoerative management, factors that often make comarisons roblematic. The overall oerative mortality in this series is similar to that reorted by other investigators. Oerative mortality rates of 4.7% to 12% have been reorted for mitral valve relacement with St. Jude and 7.5% to 13.1% with the Medtronic Hall valve [10, 11]. In our series nearly 50% of the oerative deaths were in atients with mitral insufficiency, and the most accurate redictor of oerative death was left ventricular dysfunction. It was not unexected that the leading cause of hosital mortality was erioerative heart failure. Although indeendent determinants of oerative survival for mitral valve relacement from revious studies have included coexisting coronary artery disease and female gender, they were not demonstrated to be redictors in this series. Patient survival based on 5- and 10-year actuarial estimates was not significantly different between grous. At 5 years our survival estimates (SJ, 65%; MH, 70.5%) comared favorably with those reorted in other series, which range from 59% to 78% for the St. Jude and 67% to 74% for the Medtronic Hall [12, 13]. Late survival is deendent on many factors related to the individual atient s disease and to the comlications of the rosthesis. In our study, most late deaths were a result of cardiac failure and were not related to rosthetic valve dysfunction or its attendant comlications. A more sensitive measure of valve erformance is thromboembolism, which is a major risk factor for atients with rosthetic valves. Thromboembolism was the most common valve-related comlication in this series. The incidence of thromboembolic comlications in the third-generation valvular devices has decreased dramatically. This has been because of imroved hemodynamic design resulting in better flow velocity rofile, less turbulence, and reduction of stagnant areas. In the Medtronic Hall valve, a more central osition of the disc in the oen osition enlarged the minor orifice, thus reducing stagnation of blood and turbulence in this area. The central flow design of the bileaflet St. Jude rosthesis may contribute to its low incidence of thromboembolism. In this reort, the 5-year actuarial freedom from thromboembolism was slightly better for the Medtronic Hall

6 712 FIORE ET AL Ann Thorac Surg PROSTHETIC MITRAL VALVE 1998;66: grou (SJ, 87%; MH, 94%) but by 10 years the actuarial freedom was identical in both cohorts. These figures comare favorably with those reorted by other investigators whose five-year actuarial estimates have ranged between 85% and 92% for the St. Jude valve and 85% and 94% with the Medtronic Hall valve [14, 15]. There were four cases of valve thrombosis. Noncomliance with sodium warfarin anticoagulation in the resence of atrial fibrillation was believed to have contributed to thrombus formation in 3 atients. The fourth case was a atient with metastatic lung cancer in whom valve thrombosis develoed desite an international normalized ratio of 3.0. He was not thought to be a candidate for thrombolytic theray or reoeration. All atients with thromboembolic comlications had diyridamole (300 mg daily) or asirin (5 grains) added to their anti-coagulant regimen to reduce the recurrent risk of thromboembolism. Hemorrhage was the second most common valverelated comlication. This comlication was fatal in 1 hyertensive atient in whom an intracerebral hemorrhage develoed. The actuarial freedom from hemorrhage was similarly low in both cohorts and comared favorably with that reorted in other series for the Medtronic Hall and St. Jude valves. As in most revious reorts, we noted a low rate of endocarditis with little difference between the two valves [16]. In this reort, we measured the mean transvalvular gradient at rest and after treadmill stress testing between 12 and 62 months ostoeratively using Doler echocardiograhy. No significant difference in the resting or stress-induced mean gradient could be demonstrated when both rostheses were comared in each valve size. Imroved hemodynamic erformance has been associated with symtomatic imrovement. In this series, the St. Jude and Medtronic Hall valves achieved equal imrovement in atient symtoms as evidenced by the low ostoerative NYHA functional score observed in both cohorts. The results of this study indicate that in the first 10 years after imlantation, the erformance of the St. Jude and Medtronic Hall rostheses are comarable. These two valves are among the best of the modern generation of rostheses, and either may be confidently recommended for valve relacement. The choice of valve should be based on the surgeon s exerience and reference, which may be linked to other factors such as ease of insertion, availability, and cost. Clearly, this study suggests that neither valve can claim suerior erformance or safety. We thank Terri Wriley for rearation of the manuscrit and gratefully acknowledge the articiation of Karen Powers, RN, and Debbie Moroney, RN, in obtaining accurate follow-u data. References 1. Princial investigators of CASS and their associates. The National Heart, Lung and Blood Institute Coronary Artery Surgery Study. Circulation 1981;63(Sul 1): Mehdirad AA, Williams GA, Bryg RJ, et al. Evaluation of left ventricular function with uright exercise: correlation of exercise Doler with ost-exercise wall motion and single lane echocardiograhic ejection fraction. Circulation 1987; 75: Hatle L, Angelsen B, Tromsdal A. Non-invasive assessment of atrioventricular ressure half-time by Doler ultrasound. Circulation 1969;60: Bryg RB, Williams GA, Labovitz AJ, Aker U, Kennedy HL. Effect of atrial fibrillation and mitral regurgitation on calculated mitral valve area: comarison of Doler, twodimensional echocardiograhy and cardiac catheterization. Am J Cardiol 1986;57: Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reorting morbidity and mortality after cardiac valvular oerations. Ann Thorac Surg 1996;62: Mantel N, Haenszel W. Statistical asects of the analysis of data from retrosective studies of disease. J Natl Cancer Inst 1959;22: Anthunes MJ. Clinical erformance of St. Jude and Medtronic Hall rostheses: a randomized comarative study. Ann Thorac Surg 1990;50: Fiore AC, Naunheim KS, D Orazio S, et al. Mitral valve relacement: randomized trial of St. Jude and Medtronic Hall rostheses. Ann Thorac Surg 1992;54: Keenan RJ, Armitage JM, Trento A, et al. Clinical exerience with the Medtronic Hall valve rosthesis. Ann Thorac Surg 1990;50: Arom KV, Nicoloff DM, Kersten TE, et al. Ten years exerience with the St. Jude Medical valve rosthesis. Ann Thorac Surg 1989;47: Vallejo JL, Gonzales-Santos JM, Albertos J, et al. Eight years exerience with the Medtronic Hall valve rosthesis. Ann Thorac Surg 1990;50: Ibrahim M, Cleland J, O Kane H, Gladstone D, Mulholland C, Craig B. The St. Jude Medical rosthesis: a thirteen-year exerience. J Thorac Cardiovasc Surg 1994;108: Anthunes MJ, Wessels A, Sadowski RG, et al. Medtronic Hall relacement in a third-world oulation grou. J Thorac Cardiovasc Surg 1988;95: Baudet EM, Oca CC, Roques XF, et al. A year exerience with the St. Jude Medical cardiac valve rosthesis. J Thorac Cardiovasc Surg 1985;90: Nitter-Hauge S, Abdelnoor M. Ten-year exerience with the Medtronic Hall valvular rosthesis. Circulation 1989;80 (Sul 1):43 8. DISCUSSION DR ALEJANDRO ARIS (Barcelona, Sain): I congratulate Dr Fiore for roving to us that bileaflet valves are basically no better than disc valves. I think that bileaflet valves were at the right lace at the right time, but by no means have solved the roblems of other mechanical valves. Two years ago at this meeting in Orlando we resented our exerience with the Monostrut valve in a large study with more than 8,000 valves imlanted in Sain. This valve, incidentally, has just been aroved by the Food and Drug Administration for its use in the United States. Our results at 10 years were very similar to those resented here today. There are several misconcetions regarding bileaflet valves. First, it rovides better hemodynamic erformance. This is wrong. We have shown that in the small aortic annulus the

Impact of Severe Postoperative Complications after Cardiac Surgery on Mortality in Patients Aged over 80 Years

Impact of Severe Postoperative Complications after Cardiac Surgery on Mortality in Patients Aged over 80 Years Ann Thorac Cardiovasc Surg 2014; 20: 383 389 Online July 31, 2013 doi: 10.5761/atcs.oa.13-02268 Original Article Imact of Severe Postoerative Comlications after Cardiac Surgery on Mortality in Patients

More information

Recurrence of Angina After Coronary Artery Bypass Surgery: Predictors and Prognosis (CASS Registry)

Recurrence of Angina After Coronary Artery Bypass Surgery: Predictors and Prognosis (CASS Registry) JACC Vol. 26, No. 4 895 Recurrence of Angina After Coronary Artery Byass Surgery: Predictors and Prognosis (CASS Registry) AIRLIE A. C. CAMERON, MD, FACC, KATHRYN B. DAVIS, PHD, FACC,* WILLIAM J. ROGERS,

More information

Retrograde cardioplegia could provide better myocardial. Evaluation of 7,000 Patients With Two Different Routes of Cardioplegia

Retrograde cardioplegia could provide better myocardial. Evaluation of 7,000 Patients With Two Different Routes of Cardioplegia Evaluation of 7,000 Patients With Two Different Routes of Cardiolegia Kit V. Arom, MD, PhD, Robert W. Emery, MD, Rebecca J. Petersen, RN, and Joseh W. Bero, MS Minneaolis Heart Institute, Minneaolis, Minnesota

More information

Thrombocytopenia After Aortic Valve Replacement With Freedom Solo Bioprosthesis: A Propensity Study

Thrombocytopenia After Aortic Valve Replacement With Freedom Solo Bioprosthesis: A Propensity Study Thrombocytoenia After Aortic Valve Relacement With Freedom Biorosthesis: A Proensity Study Alessandro Piccardo, MD, Dan Rusinaru, MD, Benoit Petitrez, MD, Paul Marticho, MD, Ioana Vaida, MD, Christohe

More information

Risk Scores Do Not Predict High Mortality After Coronary Artery Bypass Surgery in the Presence of Diastolic Dysfunction

Risk Scores Do Not Predict High Mortality After Coronary Artery Bypass Surgery in the Presence of Diastolic Dysfunction Risk Scores Do Not Predict High Mortality After Coronary Artery Byass Surgery in the Presence of Diastolic Dysfunction Lorenzo Merello, MD, Erick Riesle, MD, Javier Alburquerque, MD, Humberto Torres, MD,

More information

Contemporary Perioperative Results of Isolated Aortic Valve Replacement for Aortic Stenosis

Contemporary Perioperative Results of Isolated Aortic Valve Replacement for Aortic Stenosis Contemorary Perioerative Results of Isolated Aortic Valve Relacement for Aortic Stenosis S. Chris Malaisrie, MD, Patrick M. McCarthy, MD, Edwin C. McGee, MD, Richard Lee, MD, Vera H. Rigolin, MD, Charles

More information

Journal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 4, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00641-5 Utilization

More information

Elderly patients have an increased risk of neurologic

Elderly patients have an increased risk of neurologic Craniocervical and Aortic Atherosclerosis as Neurologic Risk Factors in Coronary Surgery Tomoko Goto, MD, Tomoko Baba, MD, Atsushi Yoshitake, MD, Yoshihiro Shibata, MD, Masashi Ura, MD, and Ryuzo Sakata,

More information

Effective: 10/01/13 p APPROVED BY: Pharmacy and Therapeutics Committee Page 1 of 5

Effective: 10/01/13 p APPROVED BY: Pharmacy and Therapeutics Committee Page 1 of 5 APPROVED BY: Pharmacy and Theraeutics Committee Page 1 of 5 Purose: To rovide safe and effective anticoagulation theray for UH atients Policy: Uon order of a hysician, hearin low molecular weight hearin

More information

Neurological Outcomes in Coronary Surgery: Independent Effect of Avoiding Cardiopulmonary Bypass

Neurological Outcomes in Coronary Surgery: Independent Effect of Avoiding Cardiopulmonary Bypass Neurological Outcomes in Coronary Surgery: Indeendent Effect of Avoiding Cardioulmonary Byass Nirav C. Patel, FRCS(C-Th), Anand P. Deodhar, MCh, Antony D. Grayson, BS, D. Mark Pullan, FRCS(C-Th), Daniel

More information

Since its introduction in 1975, extracorporeal membrane

Since its introduction in 1975, extracorporeal membrane Results of Extracororeal Membrane Oxygenation in Children With Sesis Dan M. Meyer, MD, Michael E. Jessen, MD, and the Extracororeal Life Suort Organization University of Texas Southwestern Medical Center,

More information

Valve Disease METHODS

Valve Disease METHODS Journal of the American College of Cardiology Vol. 36, No. 1, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00721-X Valve

More information

Comparing Clinical Outcomes in High-Volume and Low-Volume Off-Pump Coronary Bypass Operation Programs

Comparing Clinical Outcomes in High-Volume and Low-Volume Off-Pump Coronary Bypass Operation Programs Comaring Clinical Outcomes in High-Volume and Low-Volume Off-Pum Coronary Byass Oeration Programs Philli P. Brown, MD, Michael J. Mack, MD, Aril W. Simon, MSN, Salvatore L. Battaglia, BS, Lynn G. Tarkington,

More information

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical

More information

The operative mortality rate after redo valvular operations

The operative mortality rate after redo valvular operations Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,

More information

Analysis of 14,843 Neonatal Congenital Heart Surgical Procedures in the European Association for Cardiothoracic Surgery Congenital Database.

Analysis of 14,843 Neonatal Congenital Heart Surgical Procedures in the European Association for Cardiothoracic Surgery Congenital Database. Analysis of 14,843 Neonatal Congenital Heart Surgical Procedures in the Euroean Association for Cardiothoracic Surgery Congenital Database Andrzej Kansy, MD, PhD, Zdzislaw Tobota, MD, Przemyslaw Maruszewski,

More information

With the wide acceptance of off-pump bypass procedures,

With the wide acceptance of off-pump bypass procedures, Twelve-Month Patency With the Proximal Connector Device: A Single Center Prosective Randomized Trial Jörg Kemfert, MD, Ulrich T. Ofermann, MD, Markus Richter, MD, PhD, Torsten Bossert, MD, Friedrich W.

More information

CLINICAL COMMUNIQUE 16 YEAR RESULTS

CLINICAL COMMUNIQUE 16 YEAR RESULTS CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced

More information

The Efficacy of Tranexamic Acid Versus Epsilon Amino Caproic Acid in Decreasing Blood Loss in Patients Undergoing Mitral Valve Replacement Surgery

The Efficacy of Tranexamic Acid Versus Epsilon Amino Caproic Acid in Decreasing Blood Loss in Patients Undergoing Mitral Valve Replacement Surgery Journal of Anesthesiology 2017; 5(2): 11-18 htt://www.scienceublishinggrou.com/j/ja doi: 10.11648/j.ja.20170502.12 ISSN: 2376-7766(Print); ISSN: 2376-7774(Online) The Efficacy of Tranexamic Acid Versus

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Effects of Single Dose, Postinduction Dexamethasone on Recovery After Cardiac Surgery

Effects of Single Dose, Postinduction Dexamethasone on Recovery After Cardiac Surgery Effects of Single Dose, Postinduction on Recovery After Cardiac Surgery Jean-Pierre Yared, MD, Norman J. Starr, MD, Frederick K. Torres, MD, C. Allen Bashour, MD, Gregory Bourdakos, MD, Marion Piedmonte,

More information

Long-Term Results With the Medtronic-Hall Valvular Prosthesis

Long-Term Results With the Medtronic-Hall Valvular Prosthesis Long-Term Results With the Medtronic-Hall Valvular Prosthesis Cary W. Akins, MD Cardiac Surgical Unit, Massachusetts General Hospital, Boston, Massachusetts Background. Although more than 170,000 Medtronic-

More information

Impairment of cognitive brain function is frequently

Impairment of cognitive brain function is frequently ORIGINAL ARTICLES: CARDIOVASCULAR Cardioulmonary Byass Affects Cognitive Brain Function After Coronary Artery Byass Grafting Juliane Kilo, MD, Martin Czerny, MD, Michael Gorlitzer, MD, Daniel Zimfer, MS,

More information

Hyperglycemia or High Hemoglobin A1C: Which One is More Associated with Morbidity and Mortality after Coronary Artery Bypass Graft Surgery?

Hyperglycemia or High Hemoglobin A1C: Which One is More Associated with Morbidity and Mortality after Coronary Artery Bypass Graft Surgery? doi: 10.5761/atcs.oa.13.02282 Original Article Hyerglycemia or High Hemoglobin A1C: Which One is More Associated with Morbidity and Mortality after Coronary Artery Byass Graft Surgery? Zahra Faritous,

More information

Comparison of Water Seal and Suction After Pulmonary Lobectomy: A Prospective, Randomized Trial

Comparison of Water Seal and Suction After Pulmonary Lobectomy: A Prospective, Randomized Trial GENERAL THORACIC Comarison of Water Seal and Suction After Pulmonary Lobectomy: A Prosective, Randomized Trial Alessandro Brunelli, MD, Marco Monteverde, MD, Alessandro Borri, MD, Michele Salati, MD, Rita

More information

Journal of the American College of Cardiology Vol. 38, No. 1, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 38, No. 1, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 38, No. 1, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01308-0 Acute

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

Relationship between Left Atrial Function and Exercise Capacity in Patients with Dilated Cardiomyopathy

Relationship between Left Atrial Function and Exercise Capacity in Patients with Dilated Cardiomyopathy Med. J. Cairo Univ., Vol. 80, No. 1, December: 773-778, 2012 www.medicaljournalofcairouniversity.com Relationshi between Left Atrial Function and Exercise Caacity in Patients with Dilated Cardiomyoathy

More information

Female Sex as an Independent Predictor of Morbidity and Survival After Isolated Coronary Artery Bypass Grafting

Female Sex as an Independent Predictor of Morbidity and Survival After Isolated Coronary Artery Bypass Grafting Female Sex as an Indeendent Predictor of Morbidity and Survival After Isolated Coronary Artery Byass Grafting Waleed A. Ahmed, MD, Philli J. Tully, M. Psych (Clin), PhD, John L. Knight, FRACS, and Robert

More information

Long-term results (22 years) of the Ross Operation a single institutional experience

Long-term results (22 years) of the Ross Operation a single institutional experience Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department

More information

Journal of the American College of Cardiology Vol. 35, No. 2, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 2, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 2, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00577-X Persistent

More information

Six-Month Outcome in Patients With Myocardial Infarction Initially Admitted to Tertiary and Nontertiary Hospitals

Six-Month Outcome in Patients With Myocardial Infarction Initially Admitted to Tertiary and Nontertiary Hospitals JACC Vol. 30, No. 5 November 1, 1997:1187 92 1187 Six-Month Outcome in Patients With Myocardial Infarction Initially Admitted to Tertiary and Nontertiary Hositals JAUME MARRUGAT, MD, GINÉS SANZ, MD,* RAFEL

More information

Off-Pump Bilateral Versus Single Skeletonized Internal Thoracic Artery Grafting in Patients With Diabetes

Off-Pump Bilateral Versus Single Skeletonized Internal Thoracic Artery Grafting in Patients With Diabetes Off-Pum Bilateral Versus Single Skeletonized Internal Thoracic Artery Grafting in Patients With Diabetes Takeshi Kinoshita, MD, Tohru Asai, MD, PhD, Osamu Nishimura, MD, Tomoaki Suzuki, MD, PhD, Atsushi

More information

Acute Comparative Effect of Right and Left Ventricular Pacing in Patients With Permanent Atrial Fibrillation

Acute Comparative Effect of Right and Left Ventricular Pacing in Patients With Permanent Atrial Fibrillation Journal of the American College of Cardiology Vol. 43, No. 2, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.09.027

More information

Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5)

Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5) European Heart Journal Supplements () 3 (Supplement Q), Q39 Q43 Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

Journal of the American College of Cardiology Vol. 36, No. 4, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 36, No. 4, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 36, No. 4, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00823-8 Diabetes

More information

Nineteen-Millimeter Aortic St. Jude Medical Heart Valve Prosthesis: Up to Sixteen Years Follow-up

Nineteen-Millimeter Aortic St. Jude Medical Heart Valve Prosthesis: Up to Sixteen Years Follow-up Nineteen-Millimeter Aortic St. Jude Medical Heart Valve Prosthesis: Up to Sixteen Years Follow-up Dilip Sawant, FRCS, Arun K. Singh, MD, William C. Feng, MD, Arthur A. Bert, MD, and Fred Rotenberg, MD

More information

The risks of blood transfusion are well known. Aprotinin

The risks of blood transfusion are well known. Aprotinin Ultra-Low Dose Arotinin Decreases Transfusion Requirements and Is Cost Effective in Coronary Oerations Rebecca J. Dignan, MD, David W. Law, BSc, Peng W. Seah, MBBS, Con W. Manganas, MBBS, David C. Newman,

More information

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member

More information

Yavuz M. Bilgin, MD; Leo M. G. van de Watering, MD, PhD; Michel I. M. Versteegh, MD; Marinus H. J. van Oers, MD, PhD; Anneke Brand, MD, PhD

Yavuz M. Bilgin, MD; Leo M. G. van de Watering, MD, PhD; Michel I. M. Versteegh, MD; Marinus H. J. van Oers, MD, PhD; Anneke Brand, MD, PhD Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and ostoerative comlications* Yavuz M. Bilgin, MD; Leo M. G. van de Watering, MD, PhD; Michel I.

More information

Prognostic Value of Exercise Thallium-201 Imaging Performed Within 2 Years of Coronary Artery Bypass Graft Surgery

Prognostic Value of Exercise Thallium-201 Imaging Performed Within 2 Years of Coronary Artery Bypass Graft Surgery 848 JACC Vol. 31, No. 4 BYPASS SURGERY Prognostic of Exercise Thallium-201 Imaging Performed Within 2 Years of Coronary Artery Byass Graft Surgery TODD D. MILLER, MD, FACC, TIMOTHY F. CHRISTIAN, MD, FACC,

More information

Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular Enlargement (SAVE) Study

Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular Enlargement (SAVE) Study JACC Vol. 29, No. 2 February 1997:229 36 CLINICAL STUDIES 229 MYOCARDIAL INFARCTION Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular

More information

Severe Psychiatric Disorders in Mid-Life and Risk of Dementia in Late- Life (Age Years): A Population Based Case-Control Study

Severe Psychiatric Disorders in Mid-Life and Risk of Dementia in Late- Life (Age Years): A Population Based Case-Control Study Send Orders for Rerints to rerints@benthamscience.net Current Alzheimer Research, 2014, 11, 681-693 681 Severe Psychiatric Disorders in Mid-Life and Risk of Dementia in Late- Life (Age 65-84 Years): A

More information

The CarboMedics bileaflet prosthetic heart was introduced

The CarboMedics bileaflet prosthetic heart was introduced The CarboMedics Valve: Experience With 1,049 Implants José M. Bernal, MD, José M. Rabasa, MD, Francisco Gutierrez-Garcia, MD, Carlos Morales, MD, J. Francisco Nistal, MD, and José M. Revuelta, MD Department

More information

Ascending Aorta Aneurysm: What is the Risk of Replacing the Aortic

Ascending Aorta Aneurysm: What is the Risk of Replacing the Aortic ORIGINAL ARTICLE Ascending Aorta Aneurysm: What is the Risk of Relacing the Aortic Root? Aneurisma de aorta ascendente: cuál es el riesgo de reemlazar la raíz? MARIANO CAMPORROTONDO 1, JUAN CARLOS ESPINOZA

More information

The saphenous vein harvest wound is well recognized

The saphenous vein harvest wound is well recognized Occlusive Wra Dressing Reduces Infection Rate in Sahenous Vein Harvest Site Franklin L. Rosenfeldt, FRACS, Justin Negri, FRACS, Damien Holdaway, FRACS, Bruce B. Davis, FRACS, Julie Mack, BS, Michael J.

More information

Risk factors for post-colectomy adhesive small bowel obstruction

Risk factors for post-colectomy adhesive small bowel obstruction Original article Acta Medica Academica 2016;45(2):121-127 DOI: 10.5644/ama2006-124.167 Risk factors for ost-colectomy adhesive small bowel obstruction Edin Husarić 1, Šefik Hasukić 1, Nešad Hotić 1, Amir

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,

More information

Clinical material and methods. Copyright by ICR Publishers 2003

Clinical material and methods. Copyright by ICR Publishers 2003 Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and

More information

Abstract. Med. J. Cairo Univ., Vol. 84, No. 1, March: 77-83,

Abstract. Med. J. Cairo Univ., Vol. 84, No. 1, March: 77-83, Med. J. Cairo Univ., Vol. 84, No. 1, March: 77-83, 2016 www.medicaljournalofcairouniversity.net Effects on the Maternal Nausea and Vomiting after Giving Prohylactic Ehedrine Versus Phenylehrine for Prevention

More information

Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis

Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis Euroean Heart Journal (2008) 29, 1043 1048 doi:10.1093/eurheartj/ehm543 CLINICAL RESEARCH Valvular heart disease Inconsistencies of echocardiograhic criteria for the grading of aortic valve stenosis Jan

More information

TSDA ACGME Milestones

TSDA ACGME Milestones TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short

More information

Non-small cell lung cancer (NSCLC) is the most common

Non-small cell lung cancer (NSCLC) is the most common ORIGINAL ARTICLE Elevated Preoerative C-reactive Protein Predicts Poor Cancer Secific Survival in Patients Undergoing Resection for Non-small Cell Lung Cancer Caroline O Dowd, MBChB, MRCP,* Laura A. McRae,

More information

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background

More information

PII S (01)

PII S (01) Hemodynamic Changes With Right Lateral Decubitus Body ing in the Tilted Porcine Heart Paul F. Gründeman, MD, PhD, Cornelius Borst, MD, PhD, Cees W. J. Verlaan, Stefan Damen, MD, and Sabine Mertens, MD

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Randomized controlled trials: who fails run-in?

Randomized controlled trials: who fails run-in? Rees et al. Trials (2016) 17:374 DOI 10.1186/s13063-016-1451-9 RESEARCH Oen Access Randomized controlled trials: who fails run-in? Judy R. Rees 1, Leila A. Mott 1, Elizabeth L. Barry 1, John A. Baron 1,2,

More information

A step-down unit transfer protocol for low-risk aneurysmal subarachnoid hemorrhage

A step-down unit transfer protocol for low-risk aneurysmal subarachnoid hemorrhage NEUROSURGICAL FOCUS Neurosurg Focus 43 (5):E15, 2017 A ste-down unit transfer rotocol for low-risk aneurysmal subarachnoid hemorrhage Alexander G. Chartrain, BS, 1 Ahmed J. Awad, MD, 1 Christoher A. Sarkiss,

More information

Cardiology & Vascular Research

Cardiology & Vascular Research Research Article Cardiology & Vascular Research Benefit of -VASc Score in Predicting Imlantable Cardioverter Defibrillator Shocks Seyda GUNAY 1, Sabri SEYIS 2* and Özge KURMUŞ 3 1 Deartment of Cardiology,

More information

Cardiology & Vascular Research

Cardiology & Vascular Research Research Article Cardiology & Vascular Research ISSN 2639-8486 Correlation of Limb Bioimedance to Echocardiograhic Indicators of Congestion in Patients with NYHA Class II/III Heart Failure Accardi AJ *,

More information

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm

More information

Research Article Comparison of the Feasibility and Safety of First- versus Second-Generation AMPLATZERC Occluders for Left Atrial Appendage Closure

Research Article Comparison of the Feasibility and Safety of First- versus Second-Generation AMPLATZERC Occluders for Left Atrial Appendage Closure Hindawi BioMed Research International Volume 2017, Article ID 1519362, 7 ages htts://doi.org/10.1155/2017/1519362 Research Article Comarison of the Feasibility and Safety of First- versus Second-Generation

More information

Twenty-year experience with the St Jude Medical mechanical valve prosthesis

Twenty-year experience with the St Jude Medical mechanical valve prosthesis Surgery for Acquired Cardiovascular Disease Ikonomidis et al Twenty-year experience with the St Jude Medical mechanical valve prosthesis John S. Ikonomidis, MD, PhD John M. Kratz, MD Arthur J. Crumbley

More information

COPD is a common disease. Over the prolonged, Pneumonic vs Nonpneumonic Acute Exacerbations of COPD*

COPD is a common disease. Over the prolonged, Pneumonic vs Nonpneumonic Acute Exacerbations of COPD* vs Acute Exacerbations of COPD* David Lieberman, MD; Devora Lieberman, MD; Yevgenia Gelfer, MD; Raiesa Varshavsky, MD; Bella Dvoskin, MD, PhD; Maija Leinonen, PhD; and Maureen G. Friedman, PhD Study objective:

More information

Moyamoya disease (MMD) is a chronic cerebrovascular. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults

Moyamoya disease (MMD) is a chronic cerebrovascular. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults CLINICAL ARTICLE J Neurosurg 127:492 502, 2017 Byass surgery versus medical treatment for symtomatic moyamoya disease in adults Dong-Kyu Jang, MD, PhD, 1 Kwan-Sung Lee, MD, PhD, 2 Hyoung Kyun Rha, MD,

More information

Department of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden

Department of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden Long-Term Outcome of the Mitroflow Pericardial Bioprosthesis in the Elderly after Aortic Valve Replacement Johan Sjögren, Tomas Gudbjartsson, Lars I. Thulin Department of Cardiothoracic Surgery, Heart

More information

Evaluation of St. Jude Medical Valve s Long-term Function by Doppler Echocardiography

Evaluation of St. Jude Medical Valve s Long-term Function by Doppler Echocardiography Evaluation of St. Jude Medical Valve s Long-term Function by Doppler Echocardiography Akira Sezai, MD, Motomi Shiono, MD, Kenji Akiyama, MD, Yukihiko Orime, MD, Hiroaki Hata, MD, Shinya Yagi, MD, Tomonori

More information

Introducing the COAPT Trial

Introducing the COAPT Trial physician INFORMATION Eligible patients Symptomatic functional mitral regurgitation 3+ Not suitable candidates for open mitral valve surgery NYHA functional class II, III, or ambulatory IV Introducing

More information

Journal of the American College of Cardiology Vol. 37, No. 3, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 3, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 3, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01193-1 Prerocedural

More information

Although mitral valve replacement (MVR) is no longer the surgical

Although mitral valve replacement (MVR) is no longer the surgical Surgery for Acquired Cardiovascular Disease Ruel et al Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves Marc Ruel, MD, MPH a,b Fraser D.

More information

Prospective, Randomized Clinical Trial of the FloSeal Matrix Sealant in Cardiac Surgery

Prospective, Randomized Clinical Trial of the FloSeal Matrix Sealant in Cardiac Surgery Prosective, Randomized Clinical Trial of the Matrix Sealant in Cardiac Surgery Giusee Nasso, MD, Felice Piancone, MD, Raffaele Bonifazi, MD, Vito Romano, MD, Giusee Visicchio, MD, Carlo Maria De Filio,

More information

Effect of Levosimendan in Patients with Severe Systolic Heart Failure and Worsening Renal Function

Effect of Levosimendan in Patients with Severe Systolic Heart Failure and Worsening Renal Function Effect of Levosimendan in Patients with Severe Systolic Heart Failure and Worsening Renal Function Ali Zorlu 1, Hasan Yücel 1, Osman Can Yontar 1, Oguz Karahan 2, Izzet Tandogan 1, Nurkay Katrancioglu

More information

Risk factors for superficial wound complications in hip and knee arthroplasty

Risk factors for superficial wound complications in hip and knee arthroplasty ORIGINAL ARTICLE INFECTIOUS DISEASES Risk factors for suerficial wound comlications in hi and knee arthrolasty K. Carroll 1, M. Dowsey 1,2, P. Choong 1,2 and T. Peel 2,3 1) Deartment of Orthoaedics, St

More information

Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement

Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement Masaki Hamamoto, MD, Ko Bando, MD, Junjiro Kobayashi, MD, Toshihiko Satoh, MD, MPH, Yoshikado

More information

Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival

Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Sukumaran K. Nair, FRCS (C Th), Gauraang Bhatnagar, MBBS, Oswaldo Valencia, MD, and Venkatachalam Chandrasekaran,

More information

Isoflurane and postoperative respiratory depression following laparoscopic surgery: A retrospective propensity-matched analysis

Isoflurane and postoperative respiratory depression following laparoscopic surgery: A retrospective propensity-matched analysis BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES RESEARCH ARTICLE WWW.BJBMS.ORG and ostoerative resiratory deression following laaroscoic surgery: A retrosective roensity-matched analysis Alexandre N. Cavalcante,

More information

The Relationship Between Chronic Atrial Fibrillation and Reduced Pulmonary Function in Cases of Preserved Left Ventricular Systolic Function

The Relationship Between Chronic Atrial Fibrillation and Reduced Pulmonary Function in Cases of Preserved Left Ventricular Systolic Function ORIGINAL ARTICLE DOI 10.4070 / kcj.2009.39.9.372 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Coyright c 2009 The Korean Society of Cardiology The Relationshi Between Chronic Atrial Fibrillation and Reduced

More information

Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance

Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance W. R. Eric Jamieson, MD, a Friedrich-Christian Riess, MD, b Peter J. Raudkivi, MD, c Jacques Metras, MD, d Edward F. G. Busse,

More information

Surgical resection is the primary curative treatment modality

Surgical resection is the primary curative treatment modality ORIGINAL ARTICLE Use of a Surgical Secimen-Collection Kit to Imrove Mediastinal Lymh-Node Examination of Resectable Lung Cancer Raymond U. Osarogiagbon, MBBS, FACP,* Laura E. Miller, MD, Robert A. Ramirez,

More information

See the corresponding editorial in this issue, pp J Neurosurg Spine 18: , 2013 AANS, 2013

See the corresponding editorial in this issue, pp J Neurosurg Spine 18: , 2013 AANS, 2013 See the corresonding editorial in this issue, 109 111. J Neurosurg Sine 18:112 121, 2013 AANS, 2013 Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human

More information

Prognostic Significance of Peripheral Monocytosis After Reperfused Acute Myocardial Infarction: A Possible Role for Left Ventricular Remodeling

Prognostic Significance of Peripheral Monocytosis After Reperfused Acute Myocardial Infarction: A Possible Role for Left Ventricular Remodeling Journal of the American College of Cardiology Vol. 39, No. 2, 2002 2002 by the American College of Cardiology ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(01)01721-1 Prognostic

More information

Influence of Inhaled Corticosteroids on Community-acquired Pneumonia in Patients with Bronchial Asthma

Influence of Inhaled Corticosteroids on Community-acquired Pneumonia in Patients with Bronchial Asthma ORIGINAL ARTICLE Influence of Inhaled Corticosteroids on Community-acquired Pneumonia in Patients with Bronchial Asthma Masako TO, Yasuo TO, Hirokazu YAMADA, Chuhei OGAWA, Mamoru OTOMO, Naohito SUZUKI

More information

Journal of the American College of Cardiology Vol. 45, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.

Journal of the American College of Cardiology Vol. 45, No. 5, by the American College of Cardiology Foundation ISSN /05/$30. Journal of the American College of Cardiology Vol. 45, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.06.080

More information

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material

More information

Primary Care practice clinics within the Edmonton Southside Primary Care Network.

Primary Care practice clinics within the Edmonton Southside Primary Care Network. INR Monitoring and Warfarin Dose Adjustment Last Review: November 2016 Intervention(s) and/or Procedure: Registered Nurses (RNs) adjust warfarin dosage according to individual patient International Normalized

More information

Cutting Balloon Angioplasty versus Conventional Balloon Angioplasty for In-Stent Restenosis Treated by Intracoronary Radiation Therapy

Cutting Balloon Angioplasty versus Conventional Balloon Angioplasty for In-Stent Restenosis Treated by Intracoronary Radiation Therapy ORIGINAL ARTICLE Cutting Balloon Angiolasty versus Conventional Balloon Angiolasty for In-Stent Restenosis Treated by Intracoronary Radiation Theray Dong-Hoon Cha, MD 1, Ron Waksman, MD 2, Augusto D. Pichard,

More information

Outcomes Before and After Implementation of a Pediatric Rapid-Response Extracorporeal Membrane Oxygenation Program

Outcomes Before and After Implementation of a Pediatric Rapid-Response Extracorporeal Membrane Oxygenation Program Outcomes Before and After Imlementation of a Pediatric Raid-Resonse Extracororeal Membrane Oxygenation Program Joseh W. Turek, MD, PhD,* Nicholas D. Andersen, MD,* D. Scott Lawson, BS, CCP, Desiree Bonadonna,

More information

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart

More information

Long-term Experience with the Bjork-Shiley Monostrut Tilting Disc Valve

Long-term Experience with the Bjork-Shiley Monostrut Tilting Disc Valve J Korean Med Sci 2007; 22: 1060-4 ISSN 1011-8934 DOI: 10.3346/jkms.2007.22.6.1060 Copyright The Korean Academy of Medical Sciences Long-term Experience with the Bjork-Shiley Monostrut Tilting Disc Valve

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Diathermy versus scalpel incisions in elective abdominal surgery: a comparative study

Diathermy versus scalpel incisions in elective abdominal surgery: a comparative study International Surgery Journal Nandurkar VS et al. Int Surg J. 2018 Se;5(9):3124-3128 htt://www.ijsurgery.com ISSN 2349-3305 eissn 2349-2902 Original Research Article DOI: htt://dx.doi.org/10.18203/2349-2902.isj20183734

More information

Induced Mild Hypothermia for Ischemic Stroke Patients

Induced Mild Hypothermia for Ischemic Stroke Patients Med. J. Cairo Univ., Vol. 82, No. 2, December: 179-186, 2014 www.medicaljournalofcairouniversity.net Induced Mild Hyothermia for Ischemic Stroke Patients AHMED E.S. ELNAHRAWY, M.Sc.; MERVAT M. KHALEF,

More information

Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes

Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes Piskin et al. BMC Infectious Diseases 2012, 12:268 RESEARCH ARTICLE Oen Access Inadequate treatment of ventilator-associated and hosital-acquired neumonia: Risk factors and imact on outcomes Nihal Piskin

More information

A Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty by the Radial, Brachial and Femoral Approaches: The Access Study

A Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty by the Radial, Brachial and Femoral Approaches: The Access Study 1269 INTERVENTIONAL CARDIOLOGY A Randomized Comarison of Percutaneous Transluminal Coronary Angiolasty by the, and Aroaches: The Access Study FERDINAND KIEMENEIJ, MD, PHD, GERT JAN LAARMAN, MD, PHD, DIEGO

More information

Relation of Arterial Structure and Function to Left Ventricular Geometric Patterns in Hypertensive Adults

Relation of Arterial Structure and Function to Left Ventricular Geometric Patterns in Hypertensive Adults JACC Vol. 28, No. 3 Setember 1996:751 6 751 Relation of Arterial Structure and Function to Left Ventricular Geometric Patterns in Hyertensive Adults MARY J. ROMAN, MD, FACC, THOMAS G. PICKERING, MD, PHD,

More information

A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC

A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC Department of Invasive Cardiology, Ospedale San Giovanni Bosco, Turin, Italy *C.V. was born the 24th May 1980 Rheumatic fever during

More information

Cost Advantages of an Ad Hoc Angioplasty Strategy

Cost Advantages of an Ad Hoc Angioplasty Strategy 321 Cost Advantages of an Angiolasty Strategy CHITURU ADELE, MD,* PAUL T. VAITKUS, MD, FACC,* SUSANNAH K. WELLS, JONATHAN B. ZEHNACKER Burlington, Vermont Objectives. We sought to determine the cost advantage

More information

P have been used for mitral and aortic valve replacement

P have been used for mitral and aortic valve replacement A -Year Comparison of Mitral Valve Replacement With Carpentier-Edwards and Hancock Porcine Bioprostheses P. Perier, MD, A. Deloche, MD, S. Chauvaud, MD, J. C. Chachques, MD, J. Relland, MD, J. N. Fabiani,

More information